These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 23447481

  • 1. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ, Lat I, Mieure KD, Jennings HR, Hall JB, Kress JP.
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
    Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N.
    J Intensive Care Med; 2019 Mar; 34(11-12):910-916. PubMed ID: 28820036
    [Abstract] [Full Text] [Related]

  • 3. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.
    Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N.
    Pharmacotherapy; 2018 May; 38(5):531-538. PubMed ID: 29600824
    [Abstract] [Full Text] [Related]

  • 4. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT, Welage LS, Kraft MD, Alaniz C.
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [Abstract] [Full Text] [Related]

  • 5. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 Jun; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

  • 6. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators.
    JAMA; 2016 Aug 02; 316(5):509-18. PubMed ID: 27483065
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH.
    J Intensive Care Med; 2019 Sep 02; 34(9):761-765. PubMed ID: 28750598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug 02; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 10. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
    Vadiei N, Daley MJ, Murthy MS, Shuman CS.
    Ann Pharmacother; 2017 Mar 02; 51(3):194-202. PubMed ID: 27886982
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW.
    Ann Pharmacother; 2017 Jan 02; 51(1):13-20. PubMed ID: 27630192
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL, Lam SW, Duggal A, Torbic H, Reddy AJ, Bauer SR.
    Pharmacotherapy; 2018 Mar 02; 38(3):319-326. PubMed ID: 29328496
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N.
    J Intensive Care Med; 2019 Oct 02; 34(10):805-810. PubMed ID: 28618919
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N, Altshuler D, Merchan C, Zakhary B, Aberle C, Papadopoulos J.
    Ann Pharmacother; 2018 Aug 02; 52(8):733-739. PubMed ID: 29560736
    [Abstract] [Full Text] [Related]

  • 19. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.
    Kim WY, Jun JH, Huh JW, Hong SB, Lim CM, Koh Y.
    Shock; 2013 Dec 02; 40(6):527-31. PubMed ID: 24089010
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.